This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Fujifilm's Synapse® 3D Raises The Bar In Advanced Visualization And Analysis For Radiology And Cardiology

CHICAGO, Nov. 25, 2012 /PRNewswire/ -- RSNA 2012: Booth #8316 -- Radiologists and cardiologists interested in advanced visualization and analysis will find the innovations of Fujifilm's Synapse 3D very appealing for their diagnostic needs. Fully integrated with Synapse PACS and Cardiovascular, Synapse 3D will be one of the showcase technologies at RSNA 2012.

(Photo: http://photos.prnewswire.com/prnh/20121125/NY18096 )

"As always, we combined Fujifilm's technological heritage with our goal of listening directly to customer needs and requirements. The result is a system that will become a standard in the field," says Jim Morgan, Vice President of Medical Informatics for Fujifilm. "With one-click access and a consistent user interface, Synapse 3D is quickly building a legion of satisfied customers—about 500 around the world, including notable customers such as the University of Southern California in Los Angeles."

Synapse 3D eliminates the need to access advanced diagnostic tools from a separate workstation or with a separate login. Patient lists are synchronized with Synapse PACS, making it up to date at all times.  Now in use at some of the most important and progressive medical facilities in the U.S. and internationally, Synapse 3D has a number of intuitive, easy-to-use features:

  • Easy transition from Synapse PACS or Cardiovascular.
  • Shared left-to-right, top-to bottom workflow for all tools.
  • More than twenty-five (25) clinical applications designed for use in both general and body part-specific diagnostics.
  • IT friendly design using SSL connectivity, virtualized environment, 64-bit OS support and multiple desktop operating system support.

"We wanted Synapse 3D to support an intuitive and logical workflow for radiologists, cardiologists and other clinicians. That's why it allows users to perform such functions as creating and rotating double oblique image slices on multiple planes, quickly performing organ, vessel and bone extractions, and so much more," adds Jim Morgan. "It is important to keep the user experience uncomplicated while offering the most extensive array of tools and viewing options for specialists, researchers and others who have unique patient care needs. They can all customize their preferred settings."

Synapse 3D will be part of the Fujifilm's exhibit at RSNA 2012, which runs through November 30, 2012 at McCormick Place in Chicago.

About FujifilmFUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc., supplies high quality, technologically advanced, FUJINON brand endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit www.fujimed.com.

SOURCE FUJIFILM Medical Systems U.S.A., Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,214.42 -10.15 -0.06%
S&P 500 2,110.74 -3.12 -0.15%
NASDAQ 4,987.89 +20.7530 0.42%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs